Patents by Inventor Paulo Fontoura

Paulo Fontoura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nogo epitopic fragments for modulating immune response
    Patent number: 7867976
    Abstract: Epitopic fragments of Nogo, including Nogo 45-66, elicit a specific and strong T cell response, and a B cell response. T cells reactive to Nogo antigens are capable of ameliorating ongoing disease, which may be induced with other antigens. The present invention provides compositions and methods for the identification and use of Nogo epitopic fragments in the treatment of immune related disease.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: January 11, 2011
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence Steinman, Hideki Garren, Paulo Fontoura
  • POLYNUCLEOTIDE THERAPY
    Publication number: 20090281170
    Abstract: This invention provides a method of treating or preventing a disease in an animal associated with one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present or involved in a non-physiologic process in the animal comprising administering to the animal a self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) associated with the disease. Administration of the self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) modulates an immune response to the self-protein(s), -polypeptide(s) or -peptide(s) expressed from administration of the self-vector.
    Type: Application
    Filed: May 18, 2009
    Publication date: November 12, 2009
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Bayhill Therapeutics/Stanford
    Inventors: Paulo Fontoura, Hideki Garren, William H. Robinson, Lawrence Steinman, Pedro Jose Ruiz, Paul J. Utz
  • POLYNUCLEOTIDE THERAPY
    Publication number: 20090264515
    Abstract: This invention provides a method of treating or preventing a disease in an animal associated with one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present or involved in a non-physiologic process in the animal comprising administering to the animal a self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) associated with the disease. Administration of the self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) modulates an immune response to the self-protein(s), -polypeptide(s) or -peptide(s) expressed from administration of the self-vector.
    Type: Application
    Filed: May 18, 2009
    Publication date: October 22, 2009
    Applicants: The Board of Trustees of the Leland Stanford Junior University, Bayhill Therapeutics/Stanford
    Inventors: Paulo Fontoura, Hideki Garren, William H. Robinson, Lawrence Steinman, Pedro Jose Ruiz, Paul J. Utz
  • Polynucleotide therapy
    Patent number: 7544669
    Abstract: This invention provides a method of treating or preventing a disease in an animal associated with one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present or involved in a non-physiologic process in the animal comprising administering to the animal a self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) associated with the disease. Administration of the self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) modulates an immune response to the self-protein(s), -polypeptide(s) or -peptide(s) expressed from administration of the self-vector.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: June 9, 2009
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Paulo Fontoura, Hideki Garren, William H. Robinson, Lawrence Steinman, Pedro Jose Ruiz, Paul J. Utz
  • Novel Immunomodulating Peptide
    Publication number: 20070280954
    Abstract: Epitopic fragments of Nogo, including Nogo 45-66, elicit a specific and strong T cell response, and a B cell response. T cells reactive to Nogo antigens are capable of ameliorating ongoing disease, which may be induced with other antigens. The present invention provides compositions and methods for the identification and use of Nogo epitopic fragments in the treatment of immune related disease.
    Type: Application
    Filed: May 14, 2004
    Publication date: December 6, 2007
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Lawrence Steinman, Hideki Garren, Paulo Fontoura
  • Polynucleotide therapy
    Publication number: 20030148983
    Abstract: This invention provides a method of treating or preventing a disease in an animal associated with one or more self-protein(s), -polypeptide(s), or -peptide(s) that is present or involved in a non-physiologic process in the animal comprising administering to the animal a self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) associated with the disease. Administration of the self-vector comprising a polynucleotide encoding the self-protein(s), -polypeptide(s) or -peptide(s) modulates an immune response to the self-protein(s), -polypeptide(s) or -peptide(s) expressed from administration of the self-vector.
    Type: Application
    Filed: November 21, 2002
    Publication date: August 7, 2003
    Inventors: Paulo Fontoura, Hideki Garren, William H. Robinson, Lawrence Steinman, Pedro Jose Ruiz, Paul J. Utz